| Literature DB >> 34708738 |
Rajvardhan Azad1, Sony Sinha2, Prateek Nishant3.
Abstract
Increasing prevalence of diabetes mellitus warrants recognition of factors related to asymmetric diabetic retinopathy (DR). This thematic synthesis based on an iterative literature review conducted in Medline and Google Scholar pertaining to diabetes with coexistent asymmetry of retinopathy included 45 original articles, 21 case reports and series, and 18 review articles from 1965 to 2020. Asymmetric DR is defined as proliferative DR (PDR) in one eye and nonproliferative, preproliferative, background, or no DR in the other eye lasting for at least 2 years. It is observed in 5%-10% of patients with PDR. Associated factors can be divided into (i) vascular: carotid obstructive disease, ocular ischemic syndrome, and retinal vascular diseases; (ii) Inflammatory: uveitis, endophthalmitis, and Fuchs' heterochromic cyclitis; (iii) degenerative: posterior vitreous detachment, high myopia and anisometropia, uveal coloboma, retinal detachment, retinitis pigmentosa, and chorioretinal atrophy and scarring; (iv) cataract surgery and vitrectomy; and (v) miscellaneous: elevated intraocular pressure, glaucoma, amblyopia, retinal detachment, and optic atrophy. The gamut of diagnostic modalities for asymmetric DR includes thorough ocular examination, slit-lamp biomicroscopy, fundus photography, fundus fluorescein angiography, optical coherence tomography, and newer modalities such as ultra-widefield fluorescein angiography and optical coherence tomography angiography, along with a complete systemic evaluation and carotid Doppler studies. The differential diagnosis includes other causes of retinal neovascularization that may present in an asymmetric manner, such as sickle cell retinopathy, retinal vein occlusions, and featureless retina. This review discusses in detail the aforementioned considerations and draws a comprehensive picture of asymmetric DR in order to sensitize ophthalmologists to this important condition.Entities:
Keywords: Carotid artery disease; diabetes mellitus; neovascularization; ocular ischemic syndrome
Mesh:
Year: 2021 PMID: 34708738 PMCID: PMC8725155 DOI: 10.4103/ijo.IJO_1525_21
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Historical Definitions of Asymmetric Diabetic Retinopathy
| Authors | Year | Classification system for DR | Definition | Minimum duration of follow-up |
|---|---|---|---|---|
| Gay and Rosenbaum[ | 1966 | Ballantyne’s classification | Difference of at least two stages between the two eyes | 1 year. |
| Valone[ | 1981 | Grading of angiopathy and exudation in NPDR and of proliferation in PDR | PDR in one eye, and no DR or NPDR in the other eye | 3 months |
| Browning | 1988 | Diabetic Retinopathy Study | PDR in one eye, and BDR or no DR in the fellow eye | 2 years |
| Duker | 1990 | Diabetic Retinopathy Study | High-risk PDR in one eye, and no evidence of concurrent PDR or PPDR in the opposite eye | 2 years |
| Schatz | 1994 | Grading of microaneurysms, hemorrhages, exudates, and macular edema on fundus photographs and fluorescein angiograms in a radius of three-disc diameters from the fovea (range of possible scores: 0-16) | Difference of more than 3 points between the two eyes. | 2 months |
DR=Diabetic retinopathy, BDR=background DR, PPDR=preproliferative DR, NPDR=nonproliferative DR, PDR=proliferative DR
Modifying Factors for Asymmetric DR Prevalence and Progression
| Modifying factors | Clinical conditions | Major mechanisms | Relationship with ipsilateral DR |
|---|---|---|---|
| Vascular | Carotid obstructive disease | Carotid stenosis occurring after DR onset causes increased ischemia | Progression |
| Carotid stenosis developing before DR with coexistent hypertension | Protection | ||
| Ocular ischemic syndrome | Added ischemia | Progression | |
| Retinal vascular diseases | Thinning of inner retina | Protection | |
| Inflammatory | Uveitis | Blood-ocular barrier breakdown | Progression |
| Endophthalmitis | As in Uveitis | Progression | |
| Fuch’s heterochromic iridocyclitis | Sympathetic denervation hypersensitivity, reflex vasoconstriction, reduced perfusion | Protection | |
| Degenerative | Posterior vitreous detachment | Removal of scaffold for neovascularization | Protection |
| Axial refractive errors | Reduced retinal metabolic demand | Protection | |
| Uveal coloboma | Lack of nutrition from the choroid in colobomatous area | Protection* | |
| Retinitis pigmentosa | Greater oxygen and nutrient flux from choroid to inner retina | Protection | |
| Healed choroiditis | Chorioretinal atrophy and scarring, reduced metabolic demand | Protection | |
| Optic atrophy | Reduced metabolic demand | Protection | |
| Surgery | Cataract surgery | Breakdown of blood-retinal barrier | Progression |
| Vitrectomy | Increased diffusion and clearing of sequestered growth factors | Protection | |
| Miscellaneous | Elevated intraocular pressure and glaucoma | Decreased metabolic demand | Protection |
| Amblyopia, visual deprivation, and retinal detachment | Decreased metabolic demand | Protection | |
| Idiopathic |
DR=diabetic retinopathy, PVD=posterior vitreous detachment, VEGF=vascular endothelial growth factor. *Cannot be conclusively opined
Associations of Ocular Ischemic Syndrome[23]
| Associations | Clinical conditions |
|---|---|
| Systemic | Atherosclerosis of internal carotid/ophthalmic artery |
| Dissecting aneurysm of the carotid artery | |
| Giant cell arteritis | |
| Fibrovascular dysplasia | |
| Takayasu arteritis | |
| Aortic arch syndrome | |
| Behçet’s disease | |
| Trauma or inflammation causing carotid artery stenosis | |
| Radiotherapy, e.g., for nasopharyngeal carcinoma | |
| Ocular | Intravitreal anti-VEGF injections |